ID   PLA2R_RABIT             Reviewed;        1458 AA.
AC   P49260;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1996, sequence version 1.
DT   25-MAY-2022, entry version 124.
DE   RecName: Full=Secretory phospholipase A2 receptor;
DE            Short=PLA2-R;
DE            Short=PLA2R;
DE   AltName: Full=180 kDa secretory phospholipase A2 receptor;
DE   AltName: Full=M-type receptor;
DE   Contains:
DE     RecName: Full=Soluble secretory phospholipase A2 receptor;
DE              Short=Soluble PLA2-R;
DE              Short=Soluble PLA2R;
DE   Flags: Precursor;
GN   Name=PLA2R1;
OS   Oryctolagus cuniculus (Rabbit).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Lagomorpha; Leporidae; Oryctolagus.
OX   NCBI_TaxID=9986;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PARTIAL PROTEIN SEQUENCE.
RC   TISSUE=Skeletal muscle;
RX   PubMed=8294398; DOI=10.1016/s0021-9258(17)42060-6;
RA   Lambeau G., Ancian P., Barhanin J., Lazdunski M.;
RT   "Cloning and expression of a membrane receptor for secretory phospholipases
RT   A2.";
RL   J. Biol. Chem. 269:1575-1578(1994).
RN   [2]
RP   FUNCTION.
RX   PubMed=7548076; DOI=10.1021/bi00040a028;
RA   Ancian P., Lambeau G., Lazdunski M.;
RT   "Multifunctional activity of the extracellular domain of the M-type (180
RT   kDa) membrane receptor for secretory phospholipases A2.";
RL   Biochemistry 34:13146-13151(1995).
RN   [3]
RP   FUNCTION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF 1432-ASN--THR-1438;
RP   SER-1433; 1434-TYR-TYR-1435; PRO-1436 AND SER-1452.
RX   PubMed=8550569; DOI=10.1074/jbc.271.1.250;
RA   Zvaritch E., Lambeau G., Lazdunski M.;
RT   "Endocytic properties of the M-type 180-kDa receptor for secretory
RT   phospholipases A2.";
RL   J. Biol. Chem. 271:250-257(1996).
CC   -!- FUNCTION: Receptor for secretory phospholipase A2 (sPLA2). Also able to
CC       bind to snake PA2-like toxins. Although its precise function remains
CC       unclear, binding of sPLA2 to its receptor participates in both positive
CC       and negative regulation of sPLA2 functions as well as clearance of
CC       sPLA2. Binding of sPLA2-IB/PLA2G1B induces various effects depending on
CC       the cell type, such as activation of the mitogen-activated protein
CC       kinase (MAPK) cascade to induce cell proliferation, the production of
CC       lipid mediators, selective release of arachidonic acid in bone marrow-
CC       derived mast cells. In neutrophils, binding of sPLA2-IB/PLA2G1B can
CC       activate p38 MAPK to stimulate elastase release and cell adhesion. May
CC       be involved in responses in pro-inflammatory cytokine productions
CC       during endotoxic shock. Also has endocytic properties and rapidly
CC       internalizes sPLA2 ligands, which is particularly important for the
CC       clearance of extracellular sPLA2s to protect their potent enzymatic
CC       activities. The soluble secretory phospholipase A2 receptor form is
CC       circulating and acts as a negative regulator of sPLA2 functions by
CC       blocking the biological functions of sPLA2-IB/PLA2G1B and sPLA2-
CC       X/PLA2G10. {ECO:0000269|PubMed:7548076, ECO:0000269|PubMed:8550569}.
CC   -!- SUBUNIT: Interacts with sPLA2-IB/PLA2G1B; this interaction mediates
CC       intracellular signaling as well as clearance of extracellular sPLA2-
CC       IB/PLA2G1B via endocytotic pathway (By similarity). Interacts with
CC       sPLA2-X/PLA2G10; this interaction mediates sPLA2-X/PLA2G10 clearance
CC       and inactivation (By similarity). {ECO:0000250|UniProtKB:Q13018,
CC       ECO:0000250|UniProtKB:Q62028}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:8550569};
CC       Single-pass type I membrane protein {ECO:0000269|PubMed:8550569}.
CC   -!- SUBCELLULAR LOCATION: [Soluble secretory phospholipase A2 receptor]:
CC       Secreted {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Lung, skeletal muscle, brain, kidney and heart.
CC   -!- DOMAIN: C-type lectin domains 3-5 mediate the interaction with
CC       phospholipase PLA2G1B. {ECO:0000250}.
CC   -!- DOMAIN: The endocytosis signal probably mediates endocytosis via
CC       clathrin-coated pits.
CC   -!- PTM: The secretory phospholipase A2 receptor form may be produced by
CC       the action of metalloproteinases. It contains all extracellular domains
CC       and only lacks transmembrane and cytosolic regions. It is however
CC       unclear whether this form is produced by proteolytic cleavage as
CC       suggested by some experiments, or by alternative splicing (By
CC       similarity). {ECO:0000250}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U03455; AAC48402.1; -; mRNA.
DR   PIR; A49707; A49707.
DR   RefSeq; NP_001075803.1; NM_001082334.1.
DR   AlphaFoldDB; P49260; -.
DR   SMR; P49260; -.
DR   STRING; 9986.ENSOCUP00000012759; -.
DR   PRIDE; P49260; -.
DR   GeneID; 100009180; -.
DR   KEGG; ocu:100009180; -.
DR   CTD; 22925; -.
DR   eggNOG; KOG4297; Eukaryota.
DR   InParanoid; P49260; -.
DR   OrthoDB; 29241at2759; -.
DR   Proteomes; UP000001811; Unplaced.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:UniProtKB-KW.
DR   GO; GO:0043274; F:phospholipase binding; ISS:UniProtKB.
DR   GO; GO:0038023; F:signaling receptor activity; ISS:UniProtKB.
DR   GO; GO:0090403; P:oxidative stress-induced premature senescence; ISS:UniProtKB.
DR   GO; GO:0090238; P:positive regulation of arachidonic acid secretion; ISS:UniProtKB.
DR   GO; GO:0001819; P:positive regulation of cytokine production; ISS:UniProtKB.
DR   GO; GO:0043517; P:positive regulation of DNA damage response, signal transduction by p53 class mediator; ISS:UniProtKB.
DR   GO; GO:0072593; P:reactive oxygen species metabolic process; ISS:UniProtKB.
DR   GO; GO:0006898; P:receptor-mediated endocytosis; ISS:UniProtKB.
DR   GO; GO:0090399; P:replicative senescence; ISS:UniProtKB.
DR   CDD; cd00062; FN2; 1.
DR   CDD; cd00161; RICIN; 1.
DR   Gene3D; 2.10.10.10; -; 1.
DR   Gene3D; 3.10.100.10; -; 8.
DR   InterPro; IPR001304; C-type_lectin-like.
DR   InterPro; IPR016186; C-type_lectin-like/link_sf.
DR   InterPro; IPR018378; C-type_lectin_CS.
DR   InterPro; IPR016187; CTDL_fold.
DR   InterPro; IPR000562; FN_type2_dom.
DR   InterPro; IPR036943; FN_type2_sf.
DR   InterPro; IPR035992; Ricin_B-like_lectins.
DR   InterPro; IPR000772; Ricin_B_lectin.
DR   Pfam; PF00040; fn2; 1.
DR   Pfam; PF00059; Lectin_C; 8.
DR   SMART; SM00034; CLECT; 8.
DR   SMART; SM00059; FN2; 1.
DR   SMART; SM00458; RICIN; 1.
DR   SUPFAM; SSF50370; SSF50370; 1.
DR   SUPFAM; SSF56436; SSF56436; 8.
DR   PROSITE; PS00615; C_TYPE_LECTIN_1; 3.
DR   PROSITE; PS50041; C_TYPE_LECTIN_2; 8.
DR   PROSITE; PS00023; FN2_1; 1.
DR   PROSITE; PS51092; FN2_2; 1.
DR   PROSITE; PS50231; RICIN_B_LECTIN; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Direct protein sequencing; Disulfide bond; Endocytosis;
KW   Glycoprotein; Lectin; Membrane; Receptor; Reference proteome; Repeat;
KW   Secreted; Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..23
FT                   /evidence="ECO:0000255"
FT   CHAIN           24..1458
FT                   /note="Secretory phospholipase A2 receptor"
FT                   /id="PRO_0000017551"
FT   CHAIN           24..?
FT                   /note="Soluble secretory phospholipase A2 receptor"
FT                   /evidence="ECO:0000250"
FT                   /id="PRO_0000311254"
FT   TOPO_DOM        24..1393
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        1394..1416
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1417..1458
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          49..113
FT                   /note="Ricin B-type lectin"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00174"
FT   DOMAIN          171..219
FT                   /note="Fibronectin type-II"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00479"
FT   DOMAIN          227..356
FT                   /note="C-type lectin 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00040"
FT   DOMAIN          374..502
FT                   /note="C-type lectin 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00040"
FT   DOMAIN          511..645
FT                   /note="C-type lectin 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00040"
FT   DOMAIN          660..798
FT                   /note="C-type lectin 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00040"
FT   DOMAIN          815..939
FT                   /note="C-type lectin 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00040"
FT   DOMAIN          954..1098
FT                   /note="C-type lectin 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00040"
FT   DOMAIN          1117..1231
FT                   /note="C-type lectin 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00040"
FT   DOMAIN          1243..1376
FT                   /note="C-type lectin 8"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00040"
FT   MOTIF           1432..1438
FT                   /note="Endocytosis signal"
FT   CARBOHYD        91
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        408
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        431
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        452
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        49..62
FT                   /evidence="ECO:0000250"
FT   DISULFID        87..104
FT                   /evidence="ECO:0000250"
FT   DISULFID        176..202
FT                   /evidence="ECO:0000250"
FT   DISULFID        190..217
FT                   /evidence="ECO:0000250"
FT   DISULFID        258..352
FT                   /evidence="ECO:0000250"
FT   DISULFID        328..344
FT                   /evidence="ECO:0000250"
FT   DISULFID        404..499
FT                   /evidence="ECO:0000250"
FT   DISULFID        476..491
FT                   /evidence="ECO:0000250"
FT   DISULFID        615..632
FT                   /evidence="ECO:0000250"
FT   DISULFID        697..794
FT                   /evidence="ECO:0000250"
FT   DISULFID        772..786
FT                   /evidence="ECO:0000250"
FT   DISULFID        838..935
FT                   /evidence="ECO:0000250"
FT   DISULFID        912..927
FT                   /evidence="ECO:0000250"
FT   DISULFID        1065..1085
FT                   /evidence="ECO:0000250"
FT   DISULFID        1207..1221
FT                   /evidence="ECO:0000250"
FT   DISULFID        1278..1373
FT                   /evidence="ECO:0000250"
FT   DISULFID        1350..1365
FT                   /evidence="ECO:0000250"
FT   MUTAGEN         1432..1438
FT                   /note="Missing: Abolishes receptor internalization."
FT                   /evidence="ECO:0000269|PubMed:8550569"
FT   MUTAGEN         1433
FT                   /note="S->P: Increases receptor internalization."
FT                   /evidence="ECO:0000269|PubMed:8550569"
FT   MUTAGEN         1434..1435
FT                   /note="YY->AA: Reduces receptor internalization."
FT                   /evidence="ECO:0000269|PubMed:8550569"
FT   MUTAGEN         1436
FT                   /note="P->A: Does not affect receptor internalization."
FT                   /evidence="ECO:0000269|PubMed:8550569"
FT   MUTAGEN         1452
FT                   /note="S->A: Does not affect receptor internalization."
FT                   /evidence="ECO:0000269|PubMed:8550569"
SQ   SEQUENCE   1458 AA;  167200 MW;  686163066DAB9511 CRC64;
     MLLSLLLLLL LGAPRRCTEG AAAALSPERV LKWQEKGIFI IQSESLKSCI QAGKSVLTLE
     SCKQPNKNML WKWVSNQHLF NIGGSGCLGL NLSNPEQPLG LYECDSTHVS LRWRCNRKMI
     TGPLQHTVQV KQDNIIVASG KRLHKWISYM SDSGDICQHV HKDLYTRKGN AHGTPCMFPF
     QYNHQWHHEC TREGRQDDSL WCATTSRYER DEKWGFCPDP TSAEVGCDAV WEKDLNSHIC
     YQFNLLSSLS WSEAHSSCQM HGGALLSIVD EAEENFIRKQ VSGEAVEVWT GLNQLDVNAG
     WQWSDGTPLS YLNWSPEISF EPFVEYHCGT FNSFMPRAWR SRNCESTLPY ICKKYLNHVD
     DEIVEKDAWK YYATDCEPGW APYHRNCYKL QKEEKTWNEA LHSCLSSNST LIDIGSLAEV
     EFLVTLLGNE NASETWIGLS SNTFPVSFEW SNGSSVIFTN WHTLEPQIFP NRSQLCVSAE
     QSEGHWKVTD CEETHFYVCK KPGHVLSDAE SGCQEGWERH GGFCYKIDTV LRSFDHASSG
     YYCPPALVTI ADRFEQAFIT SLISSVVNMK DSYFWIALQD QNDTGEYTWK TAGQKSEPVQ
     YTHWNAHQPR SSGGCVAIRG RNPIGRWEVK DCVHFKAMSL CKQPVETREK MEHEERWPFH
     PCYLDWESQP GLASCFKVFH SEKVLMKRTW REAEAFCEEF GAHLASFAHI EEENFVNELL
     HPKFNRSEER QFWIGFNKRN PLNAGSWEWS DGTPVISSFL DNNYFGEDTR NCAVYKANKT
     LLPLHCGSKR EWICKIPRDV RPKIPSWYQY DAPWLFHQDA EYLFYPHSSE WSSFEFVCGW
     LRSDILTIHS AHEQEFILSK IKALSKYGAN WWIGLQEETA NDELRWRDGT PVIYQNWDKE
     RDRSMNNQSQ RCAFISSITG LWDREECSVS MPSICKRKTF WVIEKEKDTP KQHGTCPKGW
     LYFDYKCLLV NVPKDPSNWK NWTQARDFCF DEGGTLVAIE SEVEQAFITM NLFGQTTNVW
     IGLQNDDYEK WLNGNPVAYS NWSPSDIINI PSYNTTADQK PIPLCALLSS NPNFHFTGKW
     YFEDCGKEGY GFVCEKIQDS AGHEVNTSIM DPIPNTLEYG NRTYKIINAN MTWYAAIKSC
     QLHGAELVSI TDQYHQSFLT VILSRLGHAH WIGLFTADNG LHFDWSDGTK SSFTFWKDED
     SSFLGDCVFA DTSGRWHSTA CESFLQGAIC HVPTETRPFE HPELCSETSI PWIKFKSNCY
     SFSTVLHSAS FEAAHEFCKK EGSNLLTIKD EAENSFLLEE PFAFGASVQM VWLNAQFDNE
     TVKWLDGTPA DQSNWGIRKP DMAHFEPHQC LALRIPEGVW QLSPCQKNMG FICKMKADIH
     TVKEHPGKGP SHSIVPLAVA LTLVVILAII TLSFYIYKQN KGFFRRLAGV GNSYYPTTNF
     STIHLEENIL ISDLEKND
//
